Abstract: A weight loss product comprises a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora (in the weight proportion 12:10:5:4), to which additional ingredients have been added to increase weight loss efficacy.

Abstract: A method of enhancing weight loss involves administering to an overweight human a weight loss product that includes a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora (in the weight proportion 12:10:5:4), to which is added at least one herbal ingredient such as Malpighia glabra. As additional ingredients at least one of Conjugated linoleic acid and caffeine can be provided, with the caffeine in the form of caffeine anhydrous, Coffea Arabica, Coffea canephora, Camellia sinensis, Ilex paraguariensis, Guarana, Theobroma cacao, and kola nut. In one preferred embodiment the method involves administering, optionally in tablet form, a composition consisting essentially of the mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora; caffeine anhydrous; Vitamin C; Lyceum barbarum; Malpighia glabra; Blueberry; Punica granatum; Bilberry; and one or more excipients. Other ingredients may be used as well in accordance with specific disclosed formulations.

Abstract: A composition comprising caffeine, L-theanine, and Coleus forskohlii is provided. The composition is useful in methods for increasing perceived energy, cognitive focus, and thermogenesis. The method is also useful for aiding in weight loss or weight maintenance and may be particularly useful for improving exercise performance.

Abstract: The present invention relates to compositions comprising plants and extracts of plants with chlorogenic acids and antioxidants and/or caffeine; methods for preparing the same; and methods to promote weight loss through the administration of compositions containing these plants and plant extracts in specific proportions.

Abstract: A weight loss product comprises a mixture of Alchemilla vulgaris, Olea europaea, Cuminum cyminum, and Mentha longiflora (in the weight proportion 12:10:5:4), to which additional ingredients have been added to increase weight loss efficacy.

Abstract: The present invention relates to compositions comprising plants and extracts of plants with chlorogenic acids and antioxidants and/or caffeine; methods for preparing the same; and methods to promote weight loss through the administration of compositions containing these plants and plant extracts in specific proportions.

Abstract: The present invention relates to novel methods and compositions comprising casein, creatine or derivatives of creatine, branched chain amino acids and proteases useful for increasing lean muscle mass after exercise.

Abstract: A composition comprising at least a therapeutically effective amount of L-carnitine fumarate, and an extract of Coleus forskohlii is provided to maintain androgen and androgen-like uptake potential in cells, via simultaneous increase in the availability of androgen receptors and improved availability of androgen and androgen-like molecules. A method of same is also provided. The present invention further comprises therapeutically effective amounts of one or more of N-acetyl L-carnitine, melatonin. ubidecarenone (coenzyme Q10), idebenone, decylubiquinone, an extract of Agaricus blazei Murill, and ginsenoside Rb1.

Abstract: The present invention relates to compositions and methods for improving skeletal muscle protein metabolism through encouraging skeletal muscle protein synthesis, reducing skeletal muscle protein degradation, and attenuating inflammatory signaling in exercising muscle.

Abstract: The present invention relates to compositions and methods for improving skeletal muscle protein metabolism through encouraging skeletal muscle protein synthesis, reducing skeletal muscle protein degradation, and attenuating inflammatory signaling in exercising muscle.

Abstract: A nutritional composition comprising at least L-carnitine fumarate, red wine extract, and saw palmetto extract is provided to maintain skeletal muscle androgen receptivity, via simultaneous increase in the availability of androgen receptors and improved availability of testosterone, while at the same time reducing some of the adverse effects of increased testosterone levels. A method of same is also provided. The present invention further comprises one or more of N-acetyl L-Carnitine, Ubidecarenone (coenzyme Q10), Idebenone, Decylubiquinone, Astaxanthin, and Ginsenoside Rb1.

Abstract: A nutritional composition comprising at least an effective amount of geranylgeranylacetone or derivative of geranygeranylacetone and/or paeoniflorin or derivative of paeoniflorin and an effective amount of Schisandrin B, wherein the ingredients act substantially simultaneously, via differing mechanism, to enhance the expression of heat shock protein in cells, particularly heat shock protein 72 in skeletal muscle. A method of same is also provided.

Abstract: A nutritional composition comprising at least an effective amount of geranylgeranylacetone or derivative of geranygeranylacetone and/or paeoniflorin or derivative of paeoniflorin and an effective amount of Schisandrin B, wherein the ingredients act substantially simultaneously, via differing mechanism, to enhance the expression of heat shock protein in cells, particularly heat shock protein 72 in skeletal muscle. A method of same is also provided.

Abstract: The present invention relates to compositions and methods for improving skeletal muscle protein metabolism through encouraging skeletal muscle protein synthesis, reducing skeletal muscle protein degradation, and attenuating inflammatory signaling in exercising muscle.

Abstract: A composition comprising at least a therapeutically effective amount of L-carnitine fumarate, and an extract of Coleus forskohlii is provided to maintain androgen and androgen-like uptake potential in cells, via simultaneous increase in the availability of androgen receptors and improved availability of androgen and androgen-like molecules. A method of same is also provided. The present invention further comprises therapeutically effective amounts of one or more of N-acetyl L-carnitine, melatonin. ubidecarenone (coenzyme Q10), idebenone, decylubiquinone, an extract of Agaricus blazei Murill, and ginsenoside Rb1.

Abstract: A dietary supplement comprising at least an effective amount of Cissus quadrangularis extract and an effective amount of ?-butyrobetaine. The ingredients of the present dietary supplement act substantially to facilitate a more favorable blood lipid profile, and increase the catabolism of free fatty acids via the phosphorylation of perilipins. In additional aspects of the present invention ?-butrybetaine ethyl ester is added to the dietary supplement to provide further synergistic or additional benefits. Both a composition and a method are provided by the present disclosure.

Abstract: A nutritional supplement comprising at least a therapeutically effective amount of green tea extract and a therapeutically effective amount of ?-butyrobetaine is provided by the present invention. The ingredients of the present nutritional supplement act substantially simultaneously to induce lipolysis, resulting in free fatty acid release, and increase the catabolism of free fatty acids via the phosphorylation of perilipins. In an additional aspect of the present invention ?-butyrobetaine ethyl ester is added to the nutritional supplement to provide further synergistic or additional benefits. Both a composition and a method are provided by the present disclosure.